Background: Reference-based pricing limits reimbursement for a group of drugs that are
deemed therapeutically equivalent to the cost of the lowest-priced product within that group …

Objective. To estimate the effect of reference pricing (RP) of nonsteroidal anti‐inflammatory
drugs (NSAIDs) on drug subsidy program and beneficiary expenditures on analgesic drugs …

Reference pricing (RP) limits drug plan reimbursement of interchangeable medicines to a
reference price, which is typically equal to the price of the lowest‐cost interchangeable drug; …

Background: Reference drug pricing (RP) is a cost-sharing strategy commonly used to
control drug expenditures. Under RP, a benefit plan fully reimburses medications that are …

Background: Increasing copayments for higher-priced prescription medications has been
suggested as a means to help finance drug coverage for elderly patients, but evaluations of …

© 1999 Canadian Medical Association hibitor for the treatment of congestive heart failure1 2
and the prevention of diabetic nephropathy. 1 3, 1 4 Although the patients in this cohort were …

The United States relies primarily on market forces to determine prices for drugs, whereas
most other industrialized countries use a variety of approaches to determine drug prices …

Nitroprusside and Isoproterenol Use after Major Price Increases | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Background: Reference-based pricing is a cost-containment policy applied to prescription
drugs that are in the same class and deemed to be therapeutically equivalent. Recent …

OBJECTIVES: This paper investigates the pricing strategy (perfect flat pricing, perfect
monotonic pricing, intermediate) used for multiple dosage medications listed in the Ontario …